Clinical Effects of Use Polymyxin B Fixed on Fibers in Liver Transplant Patients With Severe Sepsis or Septic Shock

Transplantation Proceedings

Volumn 39, Issue 6, 2007, Pages 1953-1955

  Ruberto, F ^a   Pugliese, F ^a   D'Alio, A ^a   Martelli, S ^a   Bruno, K ^a   Marcellino, V ^a   Perrella, S ^a   Cappannoli, A ^a   Mazzarino, V ^a   Tosi, A ^a   Novelli, G ^a   Rossi, M ^a   Ginanni Corradini, S ^a   Ferretti, G ^a   Berloco, P B ^a   Pietropaoli, P ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; DOBUTAMINE; HYPERTENSIVE FACTOR; INOTROPIC AGENT; NORADRENALIN; POLYMYXIN B; POLYSTYRENE; TORAYMYXIN; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ANTIBIOTIC THERAPY; ARTERIAL PRESSURE; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEMALE; FIBER; HEMODYNAMIC PARAMETERS; HEMOPERFUSION; HUMAN; IMMOBILIZATION; LIVER TRANSPLANTATION; MALE; OXYGEN TENSION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RESPIRATORY FUNCTION; SEPSIS; SEPTIC SHOCK;

AGED; ANTI-INFECTIVE AGENTS; BLOOD PRESSURE; FEMALE; HEMOPERFUSION; HUMANS; INTENSIVE CARE UNITS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POLYLYSINE; POLYMYXIN B; POSTOPERATIVE COMPLICATIONS; SEPSIS; SHOCK, SEPTIC;

EID: 34547589580     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2007.05.064     Document Type: Article

References (11)

1. Fishman J.A., and Rubin R.H. Infection in organ-transplant recipients. N Engl J Med 338 (1998) 1741
2. Singh N., and Wagener M.M. Bacteriemias in liver transplantation recipients: shift toward gram-negative bacteria as predominant pathogens. Liver Transpl 10 (2004) 844
3. Vincent J.L., Laterre P.F., Cohen J., et al. A pilot-controlled study of a polymixyn B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection. Shock 23 (2005) 400
4. Tani T., Hanasawa K., Kodama M., et al. Correlation between plasma endotoxin, plasma cytokines, and plasmonigen activator inhibitor-1 in septic patients. World J Surg 25 (2001) 660
5. Ikeda T. Hemoadsorption in critical care. Ther Apher 6 (2002) 189
6. Goris J.A., Boekhorst T.P.A., and Nuytinck J.K.S. Multiple-organ failure. Arch Surg 120 (1985) 1109
7. Shoji H., Tani T., Hanasawa K., et al. Extracorporeal endotoxin removal by polymyxin B immobilized fiber cartridge: designing and antiendotoxin efficacy in the clinical application. Ther Apher Feb 2 (1998) 3
8. Nakamura T., Matsuda T., Suzuki Y., et al. Polymyxin B-immobilized fiber hemoperfusion. Dial Transpl 32 (2003) 602
9. Hidehiko K., Takahiro M., Kezuhiko O., et al. Early hemoperfusion with an immobilized polymyxin B fiber column eliminates humoral mediators and improves pulmonary oxygenation. Criticl Care 96 (2005) R653
10. Wang Y., Liu Y., Sarker K.P., et al. Polymyxin B binds anandamide and inhibits its cytotoxic effect. FEBS Lett 470 (2000) 151
11. Kohro S., Imaizumi H., Yamakage M., et al. Anandamide absorption by direct hemoperfusion with polymyxin B-immobolized fiber improves the prognosis and organ failure assessment score in patients with sepsis. J Anesth 20 (2006) 11